Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment

Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment

The neuromuscular adverse events of immune checkpoint inhibitor (ICI) treatment include myositis, polymyalgia rheumatica, myocarditis, and myasthenia syndrome. We report a 47-year old female presenting with external ophthalmoplegia, generalized muscle weakness, and third-degree atrioventricular bloc...

Full description

Bibliographic Details
Main Authors: Yue-Bei Luo, Weiting Tang, Qiuming Zeng, Weiwei Duan, Shuyu Li, Xiaosu Yang, Fangfang Bi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
myositis
myasthenia gravis
myocarditis
PD-1
toripalimab
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.714460/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.714460/full

Similar Items